Epithalons Disease-fighting, Anti-cancer, and Antioxidant Effects There is strong research interest in epithalons disease-fighting, anti-cancer, and antioxidant effects, namely in its ability to decrease experimental cancerogenesis and increase longevity in animals [3]
BPC-157 remains on the 2025 Prohibited List
Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
Oral glutathione is generally considered less invasive than intravenous (IV) glutathione administration
(2015) 6-month trial at doses up to 1,000 mg/day reported no significant adverse events [12]
If you are taking these supplements but not drinking enough water throughout the day, you may not be seeing the full benefit